Mutual of America Capital Management LLC Sells 532 Shares of Inspire Medical Systems, Inc. $INSP

Mutual of America Capital Management LLC decreased its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 12.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,789 shares of the company’s stock after selling 532 shares during the period. Mutual of America Capital Management LLC’s holdings in Inspire Medical Systems were worth $492,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the stock. Quarry LP raised its position in shares of Inspire Medical Systems by 2,127.3% in the first quarter. Quarry LP now owns 245 shares of the company’s stock valued at $39,000 after purchasing an additional 234 shares during the period. Banque Transatlantique SA bought a new stake in shares of Inspire Medical Systems in the first quarter valued at approximately $46,000. Smartleaf Asset Management LLC raised its position in shares of Inspire Medical Systems by 27.2% in the first quarter. Smartleaf Asset Management LLC now owns 454 shares of the company’s stock valued at $71,000 after purchasing an additional 97 shares during the period. Farther Finance Advisors LLC raised its position in shares of Inspire Medical Systems by 14.6% in the second quarter. Farther Finance Advisors LLC now owns 603 shares of the company’s stock valued at $78,000 after purchasing an additional 77 shares during the period. Finally, GAMMA Investing LLC raised its position in shares of Inspire Medical Systems by 253.7% in the first quarter. GAMMA Investing LLC now owns 573 shares of the company’s stock valued at $91,000 after purchasing an additional 411 shares during the period. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Trading Down 1.8%

Shares of NYSE:INSP opened at $76.80 on Wednesday. Inspire Medical Systems, Inc. has a 12 month low of $70.77 and a 12 month high of $216.01. The stock has a market cap of $2.27 billion, a P/E ratio of 44.39, a P/E/G ratio of 2.42 and a beta of 1.16. The company has a 50 day moving average of $81.97 and a 200 day moving average of $115.23.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Monday, August 4th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.23. Inspire Medical Systems had a net margin of 6.17% and a return on equity of 10.38%. The business had revenue of $217.09 million during the quarter, compared to analysts’ expectations of $214.50 million. During the same quarter in the previous year, the company earned $0.32 EPS. The business’s quarterly revenue was up 10.8% compared to the same quarter last year. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. On average, equities analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Inspire Medical Systems declared that its board has approved a share buyback program on Monday, August 11th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the company to buy up to 8.6% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Insider Buying and Selling

In other Inspire Medical Systems news, CFO Richard Buchholz sold 11,000 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $93.39, for a total value of $1,027,290.00. Following the completion of the transaction, the chief financial officer owned 44,867 shares of the company’s stock, valued at $4,190,129.13. The trade was a 19.69% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Royal Bank Of Canada reissued an “outperform” rating and issued a $150.00 price target on shares of Inspire Medical Systems in a research report on Friday, October 10th. Evercore ISI lowered their price target on shares of Inspire Medical Systems from $150.00 to $125.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 7th. Piper Sandler lowered their price target on shares of Inspire Medical Systems from $233.00 to $150.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 5th. Morgan Stanley lowered their price target on shares of Inspire Medical Systems from $200.00 to $182.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 15th. Finally, Stifel Nicolaus set a $100.00 price target on shares of Inspire Medical Systems in a research report on Friday. Seven investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $141.13.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.